Bionomics
phase trial of in adults with post traumatic stress disorder study design center randomized double blind placebo controlled and placebo liquid suspension formulation taken twice daily i week treatment period participants us sites sites key selection criteria current diagnosis of as defined by caps clinician administered scale for key study objectives to assess the effects of on investigator rated symptoms of measured by caps to assess the safety and tolerability of in subjects with be restore | Bionomics
Company
Deck Type
Sector
Industry
Deck date
April 2022
Slide
32 of 38
Similar slides by Bionomics
See diffirences between slides (animation)
IPO
December 2021
| Bionomics
Related slides by other companies
Valneva
IPO
April 2021
was highly immunogenic in phase of trial participants developed significant levels of antibodies | Valneva
BrainStorm Cell Therapeutics
Investor Presentation
October 2022
participants with are impacted by the items mealies phase featured participants with advanced als disease resulting in a floor effect | BrainStorm Cell Therapeutics
Other recent decks by Bionomics
See all presentations (5 decks)
Results
March 2023
Investor Presentation
October 2022
Investor Presentation
June 2022
IPO
December 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io